Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
NEW FRONTIERS - 19th Annual Canadian Conference on HIV/AIDS Research (CAHR 2010)
Close-Up on NRTI Backbones: Current Evidence with Preferred Regimens
Saskatoon, Saskatchewan / May 13-16, 2010
New data from the Canadian Cohort Collaboration (CANOC) has further reinforced previous evidence that the combination of abacavir and lamivudine (ABC/3TC) offers similar efficacy and safety when compared to the nucleoside reverse...
PRIORITY PRESS - Association of Medical Microbiology and Infectious Disease (AMMI) Canada/ Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID) Annual Conference
Gram-positive Infections: Putting Research into Clinical Practice
Edmonton, Alberta / May 6-8, 2010
Edmonton - Information gathered by laboratory research is often seen as lacking in clinical relevance. But in vitro clarification of the actions of bactericidal and bacteriostatic agents can actually inform drug choice when taken into...
PRIORITY PRESS - 28th Annual Meeting of the European Society of Pediatric Infectious Diseases (ESPID)
Countering Increased Vulnerability to Meningococcal Disease
Nice, France / May 4-8, 2010
Nice - The incidence of invasive meningococcal disease has dropped dramatically in Canada and most Western countries as a result of mass immunization campaigns in the 1990s. However, declining immunological protection is occurring as...
PRIORITY PRESS - 28th Annual Meeting of the European Society of Pediatric Infectious Diseases (ESPID)
Broadening Protection Against Pneumococcal Disease with Multivalent Vaccines
Nice, France / May 4-8, 2010
Nice - Streptococcus pneumoniae remains the leading cause of vaccine-preventable death worldwide, with an annual mortality of up to 1 million in young children and up to 1.6 million including the elderly. Children under 5 years of age are...
PRIORITY PRESS - American Transplant Congress 2010
Improving Long-term Outcomes in Kidney Transplant Recipients
San Diego, California / May 1-5, 2010
San Diego - The calcineurin inhibitors (CNIs) have long been the anchor of transplant immunosuppression, leading to low acute rejection rates in the short term. However, short-term gains have had little impact on long-term graft survival,...
PRIORITY PRESS - 111th Annual Digestive Disease Week (DDW)
Clinical Implications of Maximizing 5-ASA Therapy
New Orleans, Louisiana / May 1-5, 2010
New Orleans - New data have expanded the evidence that either twice-daily (b.i.d.) or once-daily mesalamine is highly effective for sustained healing and not just remission of ulcerative colitis. In a new analysis from a previously...
MEDICAL FRONTIERS - 111th Annual Digestive Disease Week (DDW)
Toward Mucosal Healing in Ulcerative Colitis
New Orleans, Louisiana / May 1-5, 2010
New Orleans - The ability of complete rather than partial healing of ulcerative colitis (UC) to provide greater protection against relapse is a rational expectation now supported by several sets of data. These data have redirected the...
MEDI-NEWS - Based on the following article: Mixed Dementia: The most common cause of dementia? Canadian Journal of Diagnosis April 2010; 35-44.
Evaluating Cognitive Decline in Mixed Dementia
April 2010
Cholinesterase inhibitors (ChEIs), which are the first-line treatment for mild-to-moderate Alzheimer's disease (AD), are also effective against mixed dementia (MD), which describes AD complicated by cerebrovascular pathology, according to a...
PRIORITY PRESS - 30th Annual Meeting of the International Society of Heart and Lung Transplantation
Vasodilation to Reverse Complications Pre- and Post-heart Transplantation
Chicago, Illinois / April 21-24, 2010
Chicago - Phosphodiesterase type-5 (PDE-5) is abundantly expressed in the lungs. By selectively inhibiting the PDE-5 enzyme, PDE-5 inhibitors promote the accumulation of intracellular cyclic guanosine monophosphate, thereby enhancing nitric...